LONDON—The European Medicines Agency, which is moving from London to Amsterdam because of Brexit, has been taken to court by its UK landlord, which wants it to keep paying a rent bill estimated at around 500 million pounds ($660 million).
Europe’s equivalent of the U.S. Food and Drug Administration signed a 25-year lease in 2014 on its premises in London’s Canary Wharf district, but it now argues Brexit amounts to an unforeseen event of “frustration” of the lease - a potential legal get-out.
